Inna Lazar, OD
Optometrist · Old Greenwich, CTNPI 1255713079
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (43.4%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 32 manufacturers reported payments, led by Lumenis BE Inc at 49.7% of the total. Among optometrist clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 353 payments — averaging $416.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lumenis BE Inc$73K
- Bausch & Lomb Americas Inc.$22K
- Sun Pharmaceutical Industries Inc.$17K
- Alcon$16K
- Coopervision Inc.$7K
- AbbVie$4K
- plus $8K from 26 others
What the payments were for
- Consulting fees$10,4607%
- Speaking & faculty fees$61,21242%
- Travel & lodging$11,5378%
- Food & beverage$63,75343%
- Education$70%
- Gifts$170%
- Entertainment$100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lumenis BE Inc | 5 | $73,077 |
| Bausch & Lomb Americas Inc. | 67 | $21,834 |
| Sun Pharmaceutical Industries Inc. | 31 | $16,663 |
| Alcon | 61 | $16,338 |
| Coopervision Inc. | 27 | $6,811 |
| AbbVie(2 entities) | 15 | $4,473 |
| Tarsus Pharmaceuticals, Inc. | 18 | $1,732 |
| Johnson & Johnson Vision Care, Inc. | 20 | $1,706 |
| Kala Pharmaceuticals, Inc. | 11 | $1,142 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 10 | $730 |
| Biotissue Holdings Inc. | 13 | $434 |
| Dompe US, Inc. | 9 | $384 |
| Oyster Point Pharma, Inc. | 11 | $264 |
| Sight Sciences, Inc. | 12 | $234 |
| ABB Con-cise Optical Group LLC | 9 | $230 |
| Novartis | 10 | $213 |
| Shire North American Group Inc | 2 | $191 |
| Eyevance Pharmaceuticals LLC | 2 | $154 |
| Amgen | 5 | $109 |
| Harrow Eye, LLC | 3 | $70 |
| Carl Zeiss Meditec USA, Inc. | 1 | $24 |
| Visioneering Technologies, Inc. | 1 | $23 |
| Topcon Healthcare, Inc. | 1 | $22 |
| LKC Technologies, Inc. | 1 | $20 |
| Oasis Medical, Inc. | 1 | $19 |
| Thea Pharma Inc. | 1 | $18 |
| Carl Zeiss Meditec AG | 1 | $17 |
| Aerie Pharmaceuticals, Inc. | 1 | $16 |
| Maculogix, Inc. | 1 | $13 |
| Tearlab Corp | 1 | $13 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $12 |
| Optos, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$146,996 in reported general payments places this provider in the 95th percentile of 574 optometrist providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XdemvyLotilaner | 15 | $28,508 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Tarsus Pharmaceuticals, Inc.Xdemvy | $1,732 | $28,50815 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 574 optometrist providers in Connecticut.
Other optometrist in Old Greenwich
- Joseph ThimonsFairfield$340K
- Jennifer StewartNew Canaan$91K
- Maria PribisStamford$78K
- Michael CooperWest Hartford$44K
- Joseph PavanoNew Britain$22K
- Susan JanikWest Hartford$20K
- Donald HigginsPlainville$18K
- Richard NowakEast Windsor$15K
- Barbara DuneHartford$14K
- Erin McClearyPlainville$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.